Photon-counting mammography is an emerging modality that allows for spectral imaging and provides a differentiation of material compositions. The development of photon-counting mammography-specific contrast agents has yet to be explored. In this study, the contrast, sensitivity, and organ dose between silver sulfide nanoparticles (AgS-NPs) and a clinically approved iodinated agent (iopamidol) were investigated using a contrast-embedded gradient ramp phantom and a prototype scanner. For a given agent, the signal intensity increased with concentration, tube voltage (kV), and high bin fraction, while remaining constant with the tube current exposure time product (mAs). Moreover, AgS-NPs produced significantly stronger contrast and improved sensitivity compared to iodine, especially when imaged at lower tube energies. Therefore, the use of photon-counting techniques and a silver-based contrast agent may markedly increase the contrast and contrast-to-noise ratios or reduce the radiation dose for contrast-enhanced mammography. Silver may be better suited than iodine for contrast agent development for spectral photon-counting mammography.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11774497 | PMC |
http://dx.doi.org/10.1021/acsanm.3c05431 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!